Wells Fargo cuts target for Ventas stock to USD 96

Published on 10/20/2026 at 13:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Wells Fargo cut its Ventas target to USD 96 on October 19, 2026. Ventas stock costs EUR 75.56 on October 20, 2026.

Valuation and reporting dates

Wells Fargo lowered its Ventas target to USD 96 on October 19, 2026.
Second-quarter revenue rose 21.70 percent to USD 1.73 billion.
Ventas stock trades at EUR 75.56 at 1:09 p.m. CEST at Lang & Schwarz on October 20, 2026.
Third-quarter results are scheduled for October 27, 2026.

Geometrisches Bauhaus-Poster mit bunten Formen und dem Schriftzug HEALTHCARE — Ventas Inc. (US92276F1003) zählt zum Gesundheitssektor, Bauhaus-Poster kombiniert geometrische Formen mit Schriftzug HEALTHCARE, Illustration mit AI erstellt.

Ventas Inc. (US92276F1003) stock was trading at EUR 75.56 at Lang & Schwarz on October 20, 2026 at 1:09 p.m. CEST. The latest analyst move came from Wells Fargo, which cut its price target from USD 104 to USD 96 on October 19, 2026, while keeping an Overweight rating, according to Markets Insider.

Target cuts reset the valuation

The USD 8 reduction leaves Wells Fargo's target below the average twelve-month consensus of USD 98.78 reported for Ventas by The Cerbat Gem. That comparison matters because the target cut arrived ahead of the company's third-quarter report, making operating performance the next test for the stock's valuation.

Three dated developments

On July 29, 2026, Ventas reported second-quarter revenue of USD 1.73 billion, up 21.70 percent year over year, and adjusted earnings per share of USD 0.97 versus a USD 0.96 consensus estimate, according to The Cerbat Gem. On October 13, 2026, a report on the company's third-quarter investor letter said Ventas was targeting 15 to 17 percent net operating income growth and had lifted its annual acquisition budget to USD 3 billion, as Yahoo Finance reported. On October 19, 2026, Wells Fargo reduced its target from USD 104 to USD 96.

What dates matter next?

Ventas is scheduled to report third-quarter 2026 results after the market close on October 27, 2026, according to Simply Wall St. Investors will have a fresh operating comparison against the second-quarter revenue growth of 21.70 percent and the USD 0.97 adjusted earnings per share figure.

Price holds the investor focus

Ventas is a healthcare real estate investment trust focused on senior housing, healthcare properties, life science and innovation centers. Its reported market capitalization was USD 43.3 billion on October 19, 2026, while its primary listing is on the NYSE under ticker VTR. The company is also included in the S&P 500.

The stock's next major information point is the October 27 report, while the recent target reductions put more weight on execution against the company's growth plans. At Lang & Schwarz, Ventas stock was trading at EUR 75.56 on October 20, 2026 at 1:09 p.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of Ventas stock.